What is the incubation period for infectious agents and how long should monitoring be performed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incubation Periods and Monitoring Duration for Infectious Agents

COVID-19 (SARS-CoV-2)

The incubation period for COVID-19 ranges from 1 to 14 days, with a median of approximately 5 days, and a 14-day monitoring period is recommended for close contacts and exposed individuals. 1, 2

Key Incubation Period Data

  • Median incubation period: 5.1 days (95% CI: 4.5-5.8 days), with 97.5% of individuals developing symptoms within 11.5 days of infection 2
  • The most common range is 3 to 7 days from exposure to symptom onset 1
  • Approximately 101 out of every 10,000 cases will develop symptoms after 14 days of monitoring under conservative assumptions 2
  • Alternative estimates from different populations show a median of 3 days (95% CI: 0.6-8.2 days) 3

Monitoring Recommendations

  • 14-day health observation period is recommended for all close contacts and persons with suspicious exposure, starting from the last day of contact with infected patients 1
  • Individuals should immediately seek medical attention if they develop fever, respiratory symptoms (coughing, shortness of breath), or diarrhea during the monitoring period 1
  • The incubation period of approximately 4 days was initially reported, with studies suggesting a range of 2 to 14 days 1

Clinical Progression Timeline

  • Mean time from symptom onset to seeking medical advice: 5.8 days 1
  • Mean time from symptom onset to hospital admission: 12.5 days 1
  • Disease stages based on CT findings: early (0-4 days), progressive (5-8 days), peak (9-13 days), and absorption (≥14 days) 1

Hepatitis A

Hepatitis A has an incubation period of approximately 4 weeks (28 days) from exposure to symptom onset. 1

  • Post-exposure prophylaxis with immune globulin should be administered as soon as possible, but no more than 2 weeks after exposure 1
  • The fecal-oral route is the primary mode of transmission 1

Hepatitis B

Hepatitis B has an incubation period ranging from 6 weeks to 6 months from exposure to symptom onset. 1

  • Contacts should receive vaccination and post-exposure prophylaxis promptly after identified exposure 1
  • Sexual transmission accounts for most HBV infections in adults in the United States 1

Influenza A (H7N9)

The median incubation period for human-to-human transmitted influenza A(H7N9) is 4 days, with a serial interval of 9 days. 4

  • China's 10-day monitoring period for close contacts should detect most secondary infections 4

General Respiratory Viral Infections

Based on systematic review of respiratory viral pathogens 5:

  • Adenovirus: 5.6 days (95% CI: 4.8-6.3)
  • Human coronavirus: 3.2 days (95% CI: 2.8-3.7)
  • Influenza A: 1.4 days (95% CI: 1.3-1.5)
  • Influenza B: 0.6 days (95% CI: 0.5-0.6)
  • Measles: 12.5 days (95% CI: 11.8-13.3)
  • Parainfluenza: 2.6 days (95% CI: 2.1-3.1)
  • Respiratory syncytial virus: 4.4 days (95% CI: 3.9-4.9)
  • Rhinovirus: 1.9 days (95% CI: 1.4-2.4)

Hand, Foot, and Mouth Disease

Peak infectiousness occurs during the first week of illness, particularly from 1 day before symptoms through 5-7 days after symptom onset. 6

Monitoring and Exclusion Recommendations

  • Children should be excluded from childcare and school for 10-14 days from symptom onset 6
  • Very young children can shed virus for up to 6 days before illness onset 6
  • Rigorous handwashing is essential during the entire infectious window 6

Tuberculosis

For tuberculosis contact investigations, the period of infectiousness is typically assumed to begin approximately 3 months before diagnosis, though it may be longer depending on symptom history. 1

  • The end of infectiousness is defined when contact is broken or when specific criteria for non-infectiousness during therapy are met 1
  • Patients with multidrug-resistant TB on inadequate therapy may remain infectious for prolonged periods 1

Important Caveats

  • Right tail considerations: When establishing quarantine policy, consider the full distribution of the incubation period, particularly the 95th-99th percentiles, as some individuals will fall outside the median range 2, 5
  • Asymptomatic transmission: For COVID-19, infected individuals can transmit the virus even when asymptomatic or presymptomatic, possessing the same viral load as symptomatic patients 1
  • Population variations: Incubation periods may vary based on age, immune status, and viral load at exposure 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Incubation period of the coronavirus disease 2019 (COVID-19) in Busan, South Korea.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020

Guideline

Period of Maximum Infectiousness for Hand, Foot, and Mouth Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.